1 month ago
10
The Invesco Biotechnology & Genome ETF (NYSEMKT:PBE) offers a focused, high-momentum attack to the biotechnology sector, portion the Vanguard Health Care ETF (NYSEMKT:VHT) provides broad, low-cost vulnerability crossed the full healthcare scenery -- from pharmaceutical giants to instrumentality makers to healthcare providers.
Snapshot (cost & size)
Beta measures terms volatility comparative to the S&P 500; beta is calculated from monthly returns implicit the disposable money past (up to 5 years). The 1-year instrumentality represents full instrumentality implicit the trailing 12 months. Dividend output is the trailing-12-month organisation yield.
Cost is simply a large differentiator here. VHT charges conscionable 0.09% a year, versus 0.58% for PBE. The funds' dividend yields are successful the aforesaid ballpark, with VHT paying 1.58% and PBE paying 1.73%
Performance & hazard examination
What's wrong
Launched successful 2004, VHT uses a passive absorption attack to way the broader healthcare assemblage and holds 423 stocks. Its largest positions see Eli Lilly (NYSE:LLY) astatine 14.2%, Johnson & Johnson (NYSE:JNJ) astatine 8.9%, and AbbVie (NYSE:ABBV) astatine 6.5%.
PBE takes a narrower path, holding 31 U.S. companies chosen for terms momentum, net growth, and absorption quality. Its apical holdings see Vertex Pharmaceuticals (NASDAQ:VRTX) astatine 5.2%, Biogen (NASDAQ:BIIB) astatine 5.1%, and Amgen (NASDAQ:AMGN) astatine 4.97%.
For much guidance connected ETF investing, cheque retired the afloat usher astatine this link.
What this means for investors
What are you looking for successful a healthcare ETF -- breadth oregon targeted bets? That's the archetypal question to inquire erstwhile deciding betwixt these 2 funds.
VHT's 423 holdings span the full healthcare manufacture -- pharma, insurers, instrumentality makers, and infirmary operators -- but that breadth is simply a spot deceptive. Like astir cap-weighted funds, VHT inactive concentrates its bets astatine the top: Eli Lilly, Johnson & Johnson, and AbbVie unsocial marque up astir 30% of the portfolio. So portion a mid-cap instrumentality maker's stumble won't dent returns much, a stumble astatine Eli Lilly -- its largest holding astatine 14% -- would inactive beryllium felt. Still, VHT's wide portfolio, paired with a 0.09% disbursal ratio, makes it a low-drama mode to enactment invested successful a assemblage that tends to clasp up reasonably good adjacent erstwhile the wide marketplace wobbles.
English (CA) · 
English (US) · 
Spanish (MX) ·